npj Parkinson s DiseaseNeurosciencePeer-reviewed journal article
Autophagy Dysfunction in iPSCs-Derived Neurons and Midbrain Organoids Carrying a SNCA Triplication
Catarina Serra-AlmeidaiD, Javier JarazoiD, Gemma Gomez‐GiroiD, Isabel RosetyiD, Alise ŽagareiD, Daniele FerranteiD, Cláudia SaraivaiD, Daniela FrangenbergiD, Jennifer ModamioiD, Elisa ZuccoliiD, Ana Clara CristóvãoiD, Liliana Inácio BernardinoiD, Jens Christian SchwamborniD
Abstract
Parkinsons disease (PD), characterized by -Synuclein aggregation and dopaminergic neuronal loss, has no current cure. Autophagy is critical for -Synuclein clearance, yet its real-time dynamics remain challenging to assess in human-relevant systems. Here, we used live-cell imaging to assess autophagy within human neuronal cultures and midbrain organoids (hMOs) derived from induced pluripotent stem cells (iPSCs) of PD patients carrying a triplication of the -Synuclein gene (3xSNCA). Using the LC3-Rosella dual-fluorescent reporter, we quantified autolysosomes dynamics in real time. In 3xSNCA neuronal cultures, we detected early autophagy defects. In 3xSNCA hMOs, reduced autolysosome area, increased total and phosphorylated -Synuclein (pS129), and decreased electrophysiological activity were observed at 50 days of differentiation (DoD). By 70 DoD, autophagy impairment became more pronounced, overlapping with dopaminergic neuron loss. These findings support the use of human iPSCs-derived models to study autophagy dysfunction in PD and demonstrate a temporal correlation between impaired autophagy, -Synuclein pathology and neuronal degeneration.
- organism: human
- assay: spatial transcriptomics
- assay: imaging
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- research focus: trajectory inference
- approach: experimental assay
- Citations
- 2
- FWCI
- 8.58
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy
Nguyen‐Vi Mohamed, Julien Sirois, … Thomas M. Durcan·Brain CommunicationsPeer-reviewed·Sep 23, 2021
- Synaptic decline precedes dopaminergic neuronal loss in human midbrain organoids harboring a triplication of the SNCA gene
Jennifer Modamio, Cláudia Saraiva, … Jens Christian Schwamborn·bioRxiv·Jul 15, 2021
- Protein aggregation and calcium dysregulation are the earliest hallmarks of synucleinopathy in human midbrain dopaminergic neurons
Gurvir S. Virdi, Minee L. Choi, … Sonia Gandhi·npj Parkinson s DiseasePeer-reviewed·Nov 24, 2022
- IPSC-derived midbrain astrocytes from Parkinson's disease patients carrying pathogenic SNCA mutations exhibit alpha-synuclein aggregation, mitochondrial fragmentation and excess calcium release
Peter A. Barbuti, Paul M. A. Antony, … Rejko Krüger·bioRxiv·Apr 27, 2020
- Midbrain organoids with an SNCA gene triplication display dopamine-dependent alterations in network activity
Ghislaine Deyab, Rhalena A. Thomas, … Edward A. Fon·bioRxiv·Apr 23, 2025
- An automated workflow for quantifying the formation of synuclein aggregates in human dopaminergic neurons
Chanshuai Han, Emmanuelle Nguyen, … Thomas M. Durcan·MethodsPeer-reviewed·Jun 15, 2026